总规模突破5万亿元！哪些ETF基金贡献最大？

Core Insights - The ETF market in China has seen a significant influx of capital this year, with various types of ETFs, including stocks, bonds, and commodities, experiencing continuous growth. The total ETF scale officially surpassed 5 trillion yuan on August 25, marking the fastest time to reach this milestone in history, reflecting the accelerating trend of passive investment [1][10]. ETF Scale Growth - The total scale of ETFs in China has crossed several key thresholds in a progressively shorter time frame: - From 4 trillion to 5 trillion yuan in just four months - From 3 trillion to 4 trillion yuan in seven months - From 2 trillion to 3 trillion yuan in ten months - The first time crossing the 1 trillion yuan mark occurred in October 2020 [2][10]. Leading ETFs - As of August 26, there are seven ETFs with a scale exceeding 100 billion yuan. The largest is the Huatai-PB CSI 300 ETF, which has surpassed 400 billion yuan, reaching 417.24 billion yuan. The second and third largest are the Huatai-PB CSI 300 ETF and the Huaxia CSI 300 ETF, with scales of 296.02 billion yuan and 218.73 billion yuan, respectively [4][10]. Year-to-Date Growth - The ETFs with the highest scale increase this year are primarily the various Huatai-PB CSI 300 ETFs. The Huatai-PB CSI 300 ETF has grown by 57.61 billion yuan, while the Huaxia CSI 300 ETF has increased by 54.72 billion yuan. Several other Huatai-PB CSI 300 ETFs have also seen growth exceeding 30 billion yuan [7][11]. Performance Rankings - The top-performing ETFs this year are dominated by Hong Kong's innovative pharmaceutical and technology sectors. The Hong Kong Stock Connect Innovative Drug ETF leads with a remarkable increase of 109.05%, with several other related ETFs also showing impressive gains exceeding 100% [8][11].